Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 862

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 4
Chunk 862
---
 remained unexercised and
outstanding and have no expiration date.

    F-22

A
summary of activity regarding warrants to purchase common stock (excluding pre-funded warrants) for the year ended December 31, 2024
were as follows:

 Schedule of Warrants Activity

    Number of  
    Weighted Average  
    Average 

    warrants  
    Exercise Price  
    Life (years) 
  
    Outstanding, December 31, 2023 
    $184,000  
    $23.20  
     2.77 
  
    Granted 
     3,280,281  
     1.40  
     5.00 
  
    Outstanding, December 31, 2024 
    $3,464,281  
    $1.89  
     4.67 

The
intrinsic value of the warrants as of December 31, 2024 is less than $0.1 million. All of the outstanding warrants are exercisable as
of December 31, 2024.

Equity
Incentive Plan

The
Company’s 2018 Equity Incentive Plan (the “2018 Plan”) provides for equity incentives to be granted to employees, executive
officers, directors and key advisers and consultants. Equity incentive grants may be made in the form of stock options with an exercise
price of not less than the fair market value of the underlying shares as determined pursuant to the 2018 Plan, restricted stock awards,
other stock-based awards, or any combination of the foregoing. The 2018 Plan is administered by the Company’s compensation committee.
The Company has reserved 3,000,000 shares of common stock for issuance under the 2018 Plan. As of December 31,
2024, 1,174,684 shares have been granted, net of forfeitures, under the 2018 Equity Incentive
Plan, of which 90,045 shares have vested.

Restricted
Stock Units

The
Company may grant restricted stock units (“RSU”) under our 2018 Plan. RSUs are bookkeeping entries representing an amount
equal to the fair market value of one share of our common stock. Subject to the provisions of the 2018 Plan, the administrator determines
the terms and conditions of RSUs, including the vesting criteria and the form and timing of payment. Notwithstanding the foregoing, the
administrator, in its sole